CELLULAR BIOMEDICINE GROUP, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities
CELLULAR BIOMEDICINE GROUP, INC. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities of $523.08 thousand as of 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability › Business Combination, Recognized Liability Assumed, Liability, Current
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities · last filed 2017-03-13
- 2016-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities $523.08K.
- 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities $523.08K.
- 2014-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities -$523.08K.
- 2014-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities -$5.73K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities |
|---|---|
| 2016-12-31 | $523.08K 10-K · filed 2017-03-13 |
| 2015-12-31 | $523.08K 10-K · filed 2016-03-14 |
| 2014-12-31 | -$523.08K 10-K · filed 2015-04-13 |
| 2014-03-31 | -$5.73K 10-Q · filed 2014-05-15 |
| 2013-12-31 | -$5.73K 10-K · filed 2014-04-15 |
| 2013-09-30 | -$5.73K 10-Q · filed 2013-12-26 |
| 2013-06-30 | -$5.73K 10-Q/A · filed 2013-12-06 |